Sivik Global Healthcare LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Sivik Global Healthcare LLC disclosed 29 US equity positions worth $182.9m in its Q1 2025 13F filing. The largest position was XBI at 11.1% of the reported book, followed by BSX and THC. Against the Q4 2024 filing, it opened 6 new positions, added to 10 and reduced 9 among the top 29 holdings.
What did Sivik Global Healthcare LLC own in Q1 2025? Top 29 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | XBI SPDR S&P BIOTECH ETF | 11.1% | $20.3m | 250,000 | 25% | added | |
| 2 | BSX BOSTON SCIENTIFIC CORPORATION | Healthcare | 5.5% | $10.1m | 100,000 | -9% | reduced |
| 3 | THC TENET HEALTHCARE | Healthcare | 5.1% | $9.4m | 70,000 | 27% | added |
| 4 | HCA HCA HEALTHCARE INC | Healthcare | 4.7% | $8.6m | 25,000 | 25% | added |
| 5 | LLY ELI LILLY & CO | Healthcare | 4.1% | $7.4m | 9,000 | -40% | reduced |
| 6 | MCK MCKESSON CORP | Healthcare | 4.0% | $7.4m | 11,000 | -27% | reduced |
| 7 | DHR DANAHER CORP | Healthcare | 3.9% | $7.2m | 35,000 | 40% | added |
| 8 | COR CENCORA INC | Healthcare | 3.8% | $7.0m | 25,000 | 0% | held |
| 9 | ISRG INTUITIVE SURG | Healthcare | 3.8% | $6.9m | 14,000 | – | new |
| 10 | CAH CARDINAL HEALTH | Healthcare | 3.8% | $6.9m | 50,000 | 0% | held |
| 11 | MDT MEDTRONIC INC | Healthcare | 3.7% | $6.7m | 75,000 | – | new |
| 12 | SYK STRYKER CORP | Healthcare | 3.6% | $6.5m | 17,500 | -12% | reduced |
| 13 | WAT WATERS CORP | Healthcare | 3.4% | $6.3m | 17,000 | 21% | added |
| 14 | UHS UNIV HEALTH SVC | Healthcare | 3.3% | $6.1m | 32,500 | -13% | reduced |
| 15 | HUM HUMANA INC. | Healthcare | 3.3% | $6.1m | 23,000 | 15% | added |
| 16 | BAX BAXTER INTERNATIONAL INC. | Healthcare | 3.3% | $6.0m | 175,000 | – | new |
| 17 | ABT ABBOTT LABS | Healthcare | 3.3% | $6.0m | 45,000 | -10% | reduced |
| 18 | A AGILENT TECHNOLOGIES INC | Healthcare | 3.2% | $5.8m | 50,000 | 43% | added |
| 19 | EHC ENCOMPASS HEALTH CORP | Healthcare | 2.9% | $5.2m | 51,600 | 15% | added |
| 20 | AZN ASTRAZENECA PLC-SPONS ADR | Healthcare | 2.8% | $5.1m | 70,000 | – | new |
| 21 | NVO NOVO-NORDISK A/S | Healthcare | 2.7% | $4.9m | 70,000 | 0% | held |
| 22 | GILD GILEAD SCIENCES INC | Healthcare | 2.5% | $4.5m | 40,000 | – | new |
| 23 | CI CIGNA GROUP/THE | Healthcare | 2.2% | $4.1m | 12,500 | 4% | added |
| 24 | SNN SMITH & NEPHEW | Healthcare | 1.9% | $3.4m | 120,000 | -4% | reduced |
| 25 | SELECT MEDICAL HOLDINGS CORP | 1.8% | $3.3m | 200,000 | 33% | added | |
| 26 | AVTR AVANTOR INC | Healthcare | 1.8% | $3.2m | 200,000 | 0% | held |
| 27 | SGRY SURGERY PARTNERS INC | Healthcare | 1.6% | $3.0m | 125,000 | -38% | reduced |
| 28 | WST WEST PHARMACEUTICAL SERVICES INC | Healthcare | 1.5% | $2.8m | 12,500 | – | new |
| 29 | UNH UNITEDHEALTH GRP | Healthcare | 1.4% | $2.6m | 5,000 | -60% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.